10X Genomics Inc (NASDAQ: TXG) is a life sciences tools company that develops and sells instruments, consumables, and software for single-cell and spatial genomics analysis. Revenue comes primarily from the sale of instruments placed in research laboratories and the recurring consumables those instruments require for each experiment, creating a razor-and-blade revenue structure. The company serves academic research institutions, biopharma companies, and other life sciences organizations globally. As of the 10-K filed February 13, 2026, 10X Genomics had completed the acquisition of Scale Biosciences, Inc., expanding its single-cell product portfolio. The company carries dual-class common stock, with Class A and Class B shares outstanding as of January 31, 2026. 10X Genomics does not pay a dividend and has historically operated at a net loss while investing heavily in product development and commercial expansion.

Revenue model

Instrument sales combined with high-margin recurring consumables sales tied to installed instrument base, creating a razor-and-blade structure. Software may accompany instrument and consumable sales.

Products and services

Single-cell genomics instruments and consumables; spatial genomics instruments and consumables; analysis software; products from acquired Scale Biosciences, Inc.

Customers and end markets

Academic and government research institutions; biopharmaceutical and biotechnology companies; life sciences researchers conducting single-cell and spatial biology experiments.

Value-chain role

Instrument and consumable manufacturer and technology platform provider to life sciences research laboratories.

Geographic exposure

Global operations; specific regional revenue breakdown not supported by available filing excerpts.

Source: SEC 10-K, filed 2026-02-13

Industry: Laboratory Analytical Instruments Peers: Neogenomics Inc Azenta Inc Cytek Biosciences Inc Syneos Health, Inc. Maravai LifeSciences Holdings Inc Medpace Holdings Inc Pacific Biosciences of California Inc Sotera Health Co Thermo Fisher Scientific Inc